Publication:
Acute kidney injury from SGLT2 inhibitors: potential mechanisms

Simple item page
dc.contributor.coauthorHahn, Kai
dc.contributor.coauthorEjaz, A. Ahsan
dc.contributor.coauthorLanaspa, Miguel A.
dc.contributor.coauthorJohnson, Richard J.
dc.contributor.departmentSchool of Medicine
dc.contributor.facultymemberYes
dc.contributor.kuauthorKanbay, Mehmet
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:36:10Z
dc.date.issued2016
dc.description.abstractSGLT2 inhibitors have shown great promise in the management of diabetes mellitus and the prevention of cardiovascular complications, but increasing evidence suggests that their use can be associated with an increased risk of acute kidney injury. Insights into the mechanisms involved might help to identify individuals who are at risk of renal injury.
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessNO
dc.description.peerreviewstatusN/A
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipThis work is supported by NIH grants DK109408‑01A1 (to R.J.J.) and DK108859‑01 (to M.A.L.)
dc.description.studentonlypublicationNo
dc.description.studentpublicationNo
dc.description.versionN/A
dc.identifier.doi10.1038/nrneph.2016.159
dc.identifier.eissn1759-507X
dc.identifier.embargoN/A
dc.identifier.endpage712
dc.identifier.grantnoDK109408‑01A1
dc.identifier.grantnoDK108859‑01
dc.identifier.issn1759-5061
dc.identifier.issue12
dc.identifier.pubmed27847389
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-84995678272
dc.identifier.startpage711
dc.identifier.urihttps://doi.org/10.1038/nrneph.2016.159
dc.identifier.urihttps://hdl.handle.net/20.500.14288/12606
dc.identifier.volume12
dc.identifier.wos000388729400001
dc.keywordsSGLT2 inhibitors
dc.keywordsAcute kidney injury
dc.keywordsAKI
dc.keywordsSodium-glucose cotransporter 2
dc.keywordsType 2 diabetes mellitus
dc.keywordsDiabetic nephropathy
dc.keywordsEmpagliflozin
dc.keywordsCanagliflozin
dc.keywordsDapagliflozin
dc.keywordsUric acid
dc.keywordsUricosuria
dc.keywordsTubular injury
dc.keywordsFructose metabolism
dc.language.isoeng
dc.publisherSpringer Nature
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofNature Reviews Nephrology
dc.relation.openaccessN/A
dc.rightsN/A
dc.subjectNephrology
dc.subjectEndocrinology
dc.subjectPharmacology
dc.titleAcute kidney injury from SGLT2 inhibitors: potential mechanisms
dc.typeOther
dspace.entity.typePublication
local.contributor.kuauthorKanbay, Mehmet
relation.isGoalOfPublicationa9786601-9431-4553-9a46-013bb366fb87
relation.isGoalOfPublication.latestForDiscoverya9786601-9431-4553-9a46-013bb366fb87
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext